GAD2 and type 1 diabetes mellitus: These results corroborated our polyclonal-stimulated PBMC studies, as patients with T1D treated with GABA and GAD65-alum demonstrated a dampened Th1 (IFNG) cytokine response following rhGAD65 stimulation.